ALX-1393
≥98%
- Product Code: 107582
CAS:
949164-09-4
| Molecular Weight: | 395.42 g./mol | Molecular Formula: | C₂₃H₂₂FNO₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
ALX-1393 is primarily used in research and development within the field of oncology. It functions as a potent and selective inhibitor of SLC6A14, an amino acid transporter that is often overexpressed in certain types of cancer cells. By blocking this transporter, ALX-1393 disrupts the supply of essential amino acids to cancer cells, thereby inhibiting their growth and proliferation. This mechanism makes it a promising candidate for targeted cancer therapies, particularly in cancers where SLC6A14 plays a critical role in tumor progression. Additionally, its selectivity helps minimize off-target effects, potentially reducing side effects compared to traditional chemotherapy. Research is ongoing to explore its efficacy in preclinical and clinical settings, with a focus on its potential to enhance treatment outcomes for patients with aggressive or resistant cancers.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Powder |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿35,982.00 |
+
-
|
ALX-1393
ALX-1393 is primarily used in research and development within the field of oncology. It functions as a potent and selective inhibitor of SLC6A14, an amino acid transporter that is often overexpressed in certain types of cancer cells. By blocking this transporter, ALX-1393 disrupts the supply of essential amino acids to cancer cells, thereby inhibiting their growth and proliferation. This mechanism makes it a promising candidate for targeted cancer therapies, particularly in cancers where SLC6A14 plays a critical role in tumor progression. Additionally, its selectivity helps minimize off-target effects, potentially reducing side effects compared to traditional chemotherapy. Research is ongoing to explore its efficacy in preclinical and clinical settings, with a focus on its potential to enhance treatment outcomes for patients with aggressive or resistant cancers.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :